Related Experiment Videos

[Association patterns of risk factors or cardiovascular disease, in a high risk Spanish population of 2,264 patients]

B Ebrí Torné1, I Ebrí Verde, J Sardaña Ferrer

  • 1Hospital Universitario Miguel Servet, Zaragoza. b.ebri@able.es

Anales De Medicina Interna (Madrid, Spain : 1984)
|December 1, 2006
PubMed

Insights

This study reveals distinct associations between cardiovascular disease risk factors and organ damage in patients with arterial hypertension (AH). Findings highlight significant correlations with cholesterol levels, smoking, and family history, varying by gender and age.

Area of Science:

  • Cardiology and Internal Medicine
  • Hypertension Research
  • Public Health

Context:

  • Arterial hypertension (AH) is a major risk factor for cardiovascular disease (CVD).
  • Understanding the complex interplay between AH risk factors and target organ damage is crucial for effective management.
  • Previous research has identified various associations, but comprehensive analysis across diverse patient demographics remains important.

Purpose:

  • To delineate the specific association patterns between cardiovascular disease risk factors and target organ lesions in patients with arterial hypertension (AH).
  • To investigate potential differences in these associations based on gender and age.
  • To compare the study's findings with existing medical literature.

Summary:

  • A nationwide cross-sectional study involving 2264 high-risk patients aged 18+ identified significant correlations between lipid profiles (total cholesterol, LDL, HDL), smoking, and family history (FH) of early cardiovascular events.
  • Left ventricular hypertrophy (LVH) showed associations with proteinuria, creatinine levels, atheromatosis, retinopathy, ischemic cardiopathy, and diabetic nephropathy.
  • Ischemic cardiopathy, proteinuria, retinopathy, elevated creatinine, atheromatosis, peripheral vascular disease (PVD), cerebrovascular disease, and age demonstrated intricate interrelationships, with notable gender-based differences observed across most variables.

Impact:

  • Provides a detailed map of cardiovascular risk factor associations with target organ damage in hypertension.
  • Highlights the importance of considering gender and age in risk assessment and clinical management of AH.
  • Offers valuable data for refining clinical guidelines and developing targeted preventive strategies for cardiovascular complications.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...